Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Martus

Showing results (321-330 of 437) with videos related to

Pageof 44
Sort By:
Journal of Psychosomatic Research|January 26, 2024
SARS-CoV-2 infection is associated with physical but not mental fatigue - Findings from a longitudinal controlled population-based studyMarisa Schurr, Florian Junne, Peter Martus, et al.
European Heart Journal|February 27, 2019
Control of blood pressure and risk of mortality in a cohort of older adults: the Berlin Initiative StudyAntonios Douros, Markus Tölle, Natalie Ebert, et al.
Journal of Cancer Research and Clinical Oncology|February 24, 2021
Reply to Andreas Boehle, Frank Kahmann, Thomas Oliver Henkel, Joerg Zimmermann and Stefan Machten's to the Letter to the editor Re: results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)Thomas Wiegel, Peter Albers, Detlef Bartkowiak, et al.
Journal of Cancer Research and Clinical Oncology|December 21, 2020
Correction to: Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)Thomas Wiegel, Peter Albers, Detlef Bartkowiak, et al.
Annals of Clinical and Translational Neurology|April 5, 2021
Neurofilament light chain is a cerebrospinal fluid biomarker in hereditary spastic paraplegiaChristoph Kessler, Lina M Serna-Higuita, Tim W Rattay, et al.
World Journal of Urology|March 20, 2020
Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trialPeter Albers, Thomas Wiegel, Heinz Schmidberger, et al.
Anticancer Research|July 31, 2012
The mTOR inhibitor everolimus in combination with carboplatin in metastatic breast cancer--a phase I trialSandra Schwarzlose-Schwarck, Christian W Scholz, Anne C Regierer, et al.
Journal of Cancer Research and Clinical Oncology|September 5, 2020
Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)Thomas Wiegel, Peter Albers, Detlef Bartkowiak, et al.
Frontiers in Oncology|October 29, 2024
AML-VAC-XS15-01: protocol of a first-in-human clinical trial to evaluate the safety, tolerability and preliminary efficacy of a multi-peptide vaccine based on leukemia stem cell antigens in acute myeloid leukemia patientsSusanne Jung, Annika Nelde, Yacine Maringer, et al.
Annals of Clinical and Translational Neurology|February 16, 2022
Characteristics of serum neurofilament light chain as a biomarker in hereditary spastic paraplegia type 4Christoph Kessler, Lina Maria Serna-Higuita, Carlo Wilke, et al.
Pageof 44

Showing results (321-330 of 437) with videos related to

Sort By:
Pageof 44
Journal of Psychosomatic Research|January 26, 2024
SARS-CoV-2 infection is associated with physical but not mental fatigue - Findings from a longitudinal controlled population-based studyMarisa Schurr, Florian Junne, Peter Martus, et al.
European Heart Journal|February 27, 2019
Control of blood pressure and risk of mortality in a cohort of older adults: the Berlin Initiative StudyAntonios Douros, Markus Tölle, Natalie Ebert, et al.
Journal of Cancer Research and Clinical Oncology|February 24, 2021
Reply to Andreas Boehle, Frank Kahmann, Thomas Oliver Henkel, Joerg Zimmermann and Stefan Machten's to the Letter to the editor Re: results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)Thomas Wiegel, Peter Albers, Detlef Bartkowiak, et al.
Journal of Cancer Research and Clinical Oncology|December 21, 2020
Correction to: Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)Thomas Wiegel, Peter Albers, Detlef Bartkowiak, et al.
Annals of Clinical and Translational Neurology|April 5, 2021
Neurofilament light chain is a cerebrospinal fluid biomarker in hereditary spastic paraplegiaChristoph Kessler, Lina M Serna-Higuita, Tim W Rattay, et al.
World Journal of Urology|March 20, 2020
Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trialPeter Albers, Thomas Wiegel, Heinz Schmidberger, et al.
Anticancer Research|July 31, 2012
The mTOR inhibitor everolimus in combination with carboplatin in metastatic breast cancer--a phase I trialSandra Schwarzlose-Schwarck, Christian W Scholz, Anne C Regierer, et al.
Journal of Cancer Research and Clinical Oncology|September 5, 2020
Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)Thomas Wiegel, Peter Albers, Detlef Bartkowiak, et al.
Frontiers in Oncology|October 29, 2024
AML-VAC-XS15-01: protocol of a first-in-human clinical trial to evaluate the safety, tolerability and preliminary efficacy of a multi-peptide vaccine based on leukemia stem cell antigens in acute myeloid leukemia patientsSusanne Jung, Annika Nelde, Yacine Maringer, et al.
Annals of Clinical and Translational Neurology|February 16, 2022
Characteristics of serum neurofilament light chain as a biomarker in hereditary spastic paraplegia type 4Christoph Kessler, Lina Maria Serna-Higuita, Carlo Wilke, et al.
Pageof 44